Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gan and Lee PharmaceuticalsSHSE:603087 -2.27%89 Days Inventory is 278.40 as of Jun. 2026, which is 43% below its 10-year median of 491.51. GuruFocus rates SHSE:603087 with a GF Score™ of 89/100 and a GF Value™ of ¥73.06 (Fairly Valued). The stock has 5 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Gan and Lee Pharmaceuticals ranks worse than 84.64% on this metric.
The historical rank and industry rank for Gan and Lee Pharmaceuticals's Days Inventory or its related term are showing as below:
SHSE:603087'
s Days Inventory Range Over the Past 10 Years
Min: 295.26 Med: 491.51 Max: 659.89
Current: 370.42
During the past 13 years, Gan and Lee Pharmaceuticals's highest Days Inventory was 659.89. The lowest was 295.26. And the median was 491.51.
SHSE:603087's Days Inventory is ranked worse than 84.64% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 176.755
vs SHSE:603087: 370.42
Inventory Turnover measures how fast the company turns over its inventory within a year.
Gan and Lee Pharmaceuticals's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.33.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Gan and Lee Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.80.
Gan and Lee Pharmaceuticals (SHSE:603087) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Gan and Lee Pharmaceuticals's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Gan and Lee Pharmaceuticals's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Gan and Lee Pharmaceuticals Days Inventory Related Terms
Gan and Lee Pharmaceuticals Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603087 vs ISRG, BDX, RMD: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Gan and Lee Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gan and Lee Pharmaceuticals Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gan and Lee Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Gan and Lee Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gan and Lee Pharmaceuticals (SHSE:603087) has a Days Inventory of 278.40 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Gan and Lee Pharmaceuticals and its competitors. This is 43% below median its historical median of 491.51. Over the past decade, Gan and Lee Pharmaceuticals' Days Inventory has ranged from 295.26 to 659.89. According to the industry distribution chart, Gan and Lee Pharmaceuticals ranks #667 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 84.6%.
Is Gan and Lee Pharmaceuticals' Days Inventory too high?
Gan and Lee Pharmaceuticals' current Days Inventory of 278.40 is 43% below median its 10-year median of 491.51. Over the past 10 years, this metric has ranged from a low of 295.26 to a high of 659.89. The Medical Devices & Instruments industry median Days Inventory is 176.76. Gan and Lee Pharmaceuticals' value of 278.40 is 57.5% above this industry median. Based on the distribution chart, Gan and Lee Pharmaceuticals ranks #667 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Gan and Lee Pharmaceuticals has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gan and Lee Pharmaceuticals' Days Inventory compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Gan and Lee Pharmaceuticals ranks #667 out of 788 companies for Days Inventory. This places Gan and Lee Pharmaceuticals in the lower half of its industry. The industry median Days Inventory is 176.76. Gan and Lee Pharmaceuticals' value of 278.40 is 57.5% above this benchmark. Historically, Gan and Lee Pharmaceuticals' own Days Inventory has ranged from 295.26 to 659.89 over the past decade. While the company's 10-year median is 491.51 vs. the industry median of 176.76, Gan and Lee Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 176.76, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gan and Lee Pharmaceuticals's current Days Inventory of 278.40 is 57.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Gan and Lee Pharmaceuticals and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 176.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gan and Lee Pharmaceuticals's current Days Inventory is 278.40, which is 43% below median its own 10-year median of 491.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gan and Lee Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Gan and Lee Pharmaceuticals (SHSE:603087) is currently considered Fairly Valued. The stock's GF Value™ is ¥73.06, compared to a current price of ¥66.34 — trading 9.2% below its estimated fair value. The current Days Inventory is 278.40, which is 43% below median its 10-year median of 491.51 and 57.5% above the Medical Devices & Instruments industry median of 176.76. Gan and Lee Pharmaceuticals' overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Gan and Lee Pharmaceuticals (SHSE:603087), the current Days Inventory is 278.40 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gan and Lee Pharmaceuticals (SHSE:603087) Overvalued in 2026?
Based on GuruFocus' analysis, Gan and Lee Pharmaceuticals stock appears to be undervalued.
The current stock price of ¥66.34 is trading 9.2% below its estimated GF Value™ of ¥73.06.
GuruFocus considers Gan and Lee Pharmaceuticals to be Fairly Valued.
Key valuation signals for SHSE:603087:
Days Inventory: 278.40 (43% below median its 10-year median of 491.51)
GF Value™: ¥73.06 vs. price of ¥66.34 (9.2% below fair value)
Industry Position: 57.5% above the Medical Devices & Instruments median (#667 of 788)
No single metric tells the full story. See the SHSE:603087 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603087 has been successfully added to your 
